The world of pharmacology, infectious diseases, and immunizations is constantly evolving.
As new guidelines are released, modern evidence published, and critical information updated… are you confident you can keep up with it?
You can with our new-and-improved online course — The Latest Pharmacology of Infectious Diseases & Immunizations: Now with Critical Coronavirus Updates.
This self-paced video training gives you:
- Practice at the forefront of current infectious disease evidence
- Insights into WHY an agent should be prescribed in a clinical scenario
- The confidence to know WHEN it’s safe to use a cephalosporin in a patient with a history of penicillin reaction
- Tips to combat bacterial resistance — with an emphasis on new antimicrobials and advances in evidence-based treatment guidelines
- Skills to expertly interpret culture and sensitivity results
- Up to 13.75 total contact hours – INCLUDING 8.6 pharmacology CE hours
- …And so much more!
Gain the most up-to-date knowledge you will want to share with your colleagues!
Get started today and become the pharmacology expert on your unit by your very next shift!
It’s critical for your patients that you stay up-to-date on proper prescribing, patient education, and monitoring procedures for a variety of drug regimens used to treat common acute and chronic infectious diseases.
Get The Latest Pharmacology of Infectious Diseases & Immunizations: Now with Critical Corona Virus Updates – Jason Cota , Only Price $67
Here's what you'll cover in this state-of-the-art online training course:
Pharmacology of Infectious Diseases & Immunizations for Advanced Practice Clinicians — with Jason Cota, PharmaD, MS
Antimicrobials
- Drug classes
- Pharmacokinetic Properties
- Concentration-dependent killing
- Time-dependent killing
- Post-antibiotic effect
- Common interactions with other drugs
Antibacterial Allergies — Sulfa and Penicillin
- Define true allergy
- Sulfonamide antibiotics vs non-antibiotics
- Penicillin — Cephalosporin cross-sensitivity
Bacteria
- Differentiation
- Normal flora
- Common pathogens
Antibacterial Resistance — Contributing Factors
- Trends
- Mechanisms of resistance
- Contributing factors
Methicillin-Resistant Staphylococcus Aureus — Community versus Hospital Acquired
- Differentiating between CA- and HA-MRSA
- Current clinical practice guidelines
- Pharmacologic management
Enterobacteriaceae Resistance
- Extended Spectrum Beta-Lactamase (ESBL)
- What are ESBLs
- Pharmacologic management
- Carbapenem-Resistant Enterobacteriaceae (CRE)
- What are CREs
- Pharmacologic management
Urinary Tract Infections
- Bacterial Etiology, Signs and Symptoms and Diagnosis
- Cystitis and pyelonephritis
- Complicated and uncomplicated
- UTIs in pregnancy
- Treatment (IDSA Guideline Treatment Algorithm)
- Acute
- Recurrent and relapse
Clostridium Difficile Infection
- Risk factors
- Pharmacology management
- Fecal Transplantation
- Probiotics literature review
Community-Acquired Pneumonia
- Bacterial etiology
- Diagnosis
- Typical vs. atypical
- Treatment (IDSA/ATS Guidelines) and monitoring
- Outpatient vs. inpatient
- Empiric treatment
Healthcare-Associated Pneumonia
- Bacterial etiology
- Treatment (IDSA/ATS Guidelines)
Upper Respiratory Tract Infections
- Sinusitis and pharyngitis
- Etiology (Viral vs. Bacterial)
- Treatment
Skin and Soft Tissue Infections
- Cellulitis
- Bacterial etiology
- Strep. vs. Staph. vs. MRSA
- Signs & symptoms
- Treatment (IDSA Guidelines)
Influenza
- Clinical features
- Diagnosis
- Pharmacology management
Immunizations (Adult)
- Types of Vaccines
- General recommendations
- Contraindications & precautions
Infection Control Challenges: Real Risks for Patients and Staff — with William “Barry” Inman, BA-BS, CIC
A Summary of Current Recommendations From the CDC, SHEA, IDSA, APIC and the Joint Commission
Get The Latest Pharmacology of Infectious Diseases & Immunizations: Now with Critical Corona Virus Updates – Jason Cota , Only Price $67
Health-Care Associated Infections: Strategies to Control-Reduce-Eliminate
- Catheter-Associated Urinary Tract Infections
- Surgical Site Infections
- Ventilator-Associated Pneumonias
- Non-ventilator Associated Infections (overlooked HAI)
- Central-Line Associated Bloodstream Infections
The Latest Multi-Drug Resistant Microorganism Guidelines
- Carbapenem-resistant enterobacteriaceae
- Clostridium difficile
- Methicillin-resistant staphylococcus aureus
- Vancomycin resistant enterococcus
- Acinetobacter baumannii
Influenza
- Avian vs. swine vs. seasonal influenza
- H1N1 pandemic results
- When to treat? When not to treat?
- Treatment with anti-virals and antibiotics
- New vaccines for flu
Vaccination Recommendations for Healthcare Personnel
- Zoster/shingles
- Pneumoccocal
- MMR, Tdap, etc.
Emerging Infectious Diseases (Zoonotic)
- Ebola: What we learned
- Mosquito-borne ("Zika", Dengue, Chickungunya, West Nile)
- Tick-borne (Lyme and Babesia)
- Cryptosporidiosis
Bloodborne Pathogens
- Hepatitis B
- Vaccination protocol for healthcare personnel
- Staff follow-up after significant exposures
- Treatments for persons chronically infected
- Outbreaks in healthcare
- Hepatitis C
- Treatment "cures" in 12-24 weeks
- Outbreaks in healthcare-dialysis settings
- HIV/AIDS
- New one pill daily treatment
- Healthcare exposure and appropriate prophylaxis
Tuberculosis
- Today's best approaches to treatment
- Skin testing vs. blood test for exposure
- Follow-up guidelines for healthcare workers conversion testing
Get The Latest Pharmacology of Infectious Diseases & Immunizations: Now with Critical Corona Virus Updates – Jason Cota , Only Price $67
Tag: The Latest Pharmacology of Infectious Diseases & Immunizations: Now with Critical Corona Virus Updates – Jason Cota Review. The Latest Pharmacology of Infectious Diseases & Immunizations: Now with Critical Corona Virus Updates – Jason Cota download. The Latest Pharmacology of Infectious Diseases & Immunizations: Now with Critical Corona Virus Updates – Jason Cota discount.
Reviews
There are no reviews yet.